American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
Upgrade
American Flag

United Therapeutics Corp

UTHR Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

Chart provided by TradingView

UTHR historical prices
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Congress Trading

Recent trades of UTHR by members of U.S. Congress

Politician Type Traded
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 31, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Oct 30, 2025
Lisa C. McClain House / R Sale $1,001 - $15,000 Oct 30, 2025
Michael T. McCaul House / R Sale $15,001 - $50,000 Oct 27, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 22, 2025
Michael T. McCaul House / R Sale $50,001 - $100,000 Aug 22, 2025
Michael T. McCaul House / R Purchase $50,001 - $100,000 Aug 07, 2025
Michael T. McCaul House / R Purchase $50,001 - $100,000 Aug 07, 2025
Michael T. McCaul House / R Sale $100,001 - $250,000 Jun 27, 2025
Lisa C. McClain House / R Purchase $1,001 - $15,000 Jun 11, 2025
Michael T. McCaul House / R Sale $100,001 - $250,000 Nov 20, 2024
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 20, 2024
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 19, 2024
Michael T. McCaul House / R Sale $250,001 - $500,000 Nov 19, 2024
Michael T. McCaul House / R Sale $1,001 - $15,000 Nov 06, 2024
Michael T. McCaul House / R Sale $15,001 - $50,000 Nov 06, 2024
Michael T. McCaul House / R Sale $100,001 - $250,000 May 12, 2023
Michael T. McCaul House / R Sale $15,001 - $50,000 May 12, 2023
Michael T. McCaul House / R Purchase $15,001 - $50,000 Mar 01, 2022
Michael T. McCaul House / R Purchase $1,001 - $15,000 Mar 01, 2022
Michael T. McCaul House / R Sale $15,001 - $50,000 Jan 28, 2022
Michael T. McCaul House / R Sale $1,001 - $15,000 Jan 28, 2022
Ro Khanna House / D Sale $1,001 - $15,000 N/A
Michael T. McCaul House / R Sale $15,001 - $50,000 Dec 23, 2021
Michael T. McCaul House / R Sale $100,001 - $250,000 Dec 23, 2021
Ro Khanna House / D Purchase $1,001 - $15,000 N/A
Michael T. McCaul House / R Purchase $1,001 - $15,000 N/A
Michael T. McCaul House / R Purchase $50,001 - $100,000 N/A
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 21, 2021
Michael T. McCaul House / R Sale $1,001 - $15,000 Jun 21, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 18, 2021
Michael T. McCaul House / R Purchase $100,001 - $250,000 Jun 18, 2021
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jun 18, 2021
Michael T. McCaul House / R Purchase $50,001 - $100,000 Jun 16, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 15, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 10, 2021
Michael T. McCaul House / R Purchase $1,001 - $15,000 Jun 10, 2021
Michael T. McCaul House / R Purchase $100,001 - $250,000 Jun 09, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 09, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 07, 2021
Michael T. McCaul House / R Purchase $100,001 - $250,000 Jun 04, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 Jun 04, 2021
Michael T. McCaul House / R Purchase $1,001 - $15,000 May 21, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 21, 2021
Michael T. McCaul House / R Purchase $100,001 - $250,000 May 20, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 20, 2021
Michael T. McCaul House / R Purchase $1,001 - $15,000 May 13, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 13, 2021
Michael T. McCaul House / R Purchase $50,001 - $100,000 May 12, 2021
Michael T. McCaul House / R Purchase $15,001 - $50,000 May 12, 2021
UTHR Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
UTHR Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
UTHR Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes in UTHR holdings by institutional investors

Insider Trading

Quarterly net insider trading by UTHR's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
View Strategy Copytrade Strategy
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

See Pricing
schema-2
Corporate Lobbying

Government lobbying spending instances

  • $80,000 Jul 19, 2026 Issue: Health Issues
  • $80,000 Apr 19, 2026 Issue: Health Issues
  • $60,000 Jan 17, 2026 Issue: Postal
  • $20,000 Oct 19, 2025 Issue: None
  • $40,000 Jan 19, 2010 Issue: Pharmacy Defense Homeland Security Science/Technology
  • $50,000 Oct 19, 2009 Issue: Pharmacy Defense Homeland Security Science/Technology
  • $40,000 Jul 20, 2009 Issue: Science/Technology Homeland Security Defense Pharmacy
  • $40,000 Apr 15, 2009 Issue: Science/Technology Pharmacy Defense Homeland Security
  • $40,000 Jan 16, 2009 Issue: Defense Pharmacy Homeland Security Science/Technology
Revolving Door

Former government officials who have lobbied for UTHR

5 former government officials from 2 congressional offices at 1 lobbying firm have lobbied for UTHR, most recently Oct 16, 2025.

  • Scott H. Peters
    Daniel Zawitoski House New Chief of Staff, Rep. Scott Peters (2018-2023); Legislative Director, Rep. Scott Peters (2015-2018); Legislative Assistant, Rep. Scott Peters (2014-2015); Legislative Correspondent, Rep. Scott Peters (2013-2014). Formerly with Scott H. Peters · TIBER CREEK GROUP · Oct 16, 2025
  • Joseph Russo House New Dir Cltn, H Approp Cmte(Jan2023-Mar 2025);SAP&Dep Dir, WH OPL(Jul2020-Jan2021);SAP&Dir Biz Otrch, WH OPL(Mar-Jul 2020);AD, WH OPL(Feb2019-Mar2020);Dep AD, WH OPL(Aug2018-Feb2019);Cltn Dir, H Jud Cmte(Jan 2014-Aug 2018);LC, Rep.Goodlatte(Jan-Dec2013). Formerly Dir Cltn, H Approp Cmte(Jan2023-Mar 2025);SAP&Dep Dir, WH OPL(Jul2020-Jan2021);S · TIBER CREEK GROUP · Oct 16, 2025
  • Corey Malmgren Congress New Sen. Bill Nelson, Deputy Legislative Director & Health Counsel (2015-2018); Rep. Sandy Levin, Legislative Counsel (2013-2015), Legislative Correspondent, Staff Assistant (2008-2009); House Committee on Ways and Means, Legal Clerk/Intern (2010). Formerly Bill Nelson · TIBER CREEK GROUP · Oct 16, 2025
  • Andrew Mckechnie Congress New Health Policy Adviser, Sen. Finance Cmte. (2009-2010); Legislative Assistant, Sen. Norm Coleman (2007-2008); Legislative Assistant, Rep. Jim Ramstad (2005-2007); Staff Assistant, Rep. Jim Ramstad (2005). Formerly Finance Cmte. · TIBER CREEK GROUP · Oct 16, 2025
  • Tom Price
    John Twomey House New Chief of Staff, HHS Office of the Asst. Sec. for Legislation (2019-2021); Policy Adviser, HHS (2017-2019); Special Asst., Office of the Secretary, HHS (2017); Staff Assistant, Rep. Tom Price (2015-2017); Intern, Rep. Doug Collins (2015). Formerly with Tom Price · TIBER CREEK GROUP · Oct 16, 2025
Corporate Lobbying

UTHR Estimated quarterly lobbying spending

Revenue Breakdown

UTHR Revenue by Segment or Geography

By Segment
By Geography
UTHR Income Statement
UTHR Balance Sheet
UTHR Cash Flow
U.S. Patents

New UTHR patent grants

  • Patent Title: Treatment for interstitial lung disease Sep. 15, 2026
  • Patent Title: Salts of treprostinil Jun. 05, 2018
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Jan. 30, 2018
  • Patent Title: Solid forms of treprostinil Nov. 21, 2017
  • Patent Title: Process for making beraprost Sep. 19, 2017
  • Patent Title: Controlled release pharmaceutical formulations Sep. 12, 2017
  • Patent Title: Parenteral formulations of treprostinil Jul. 25, 2017
  • Patent Title: Salts of treprostinil Jul. 11, 2017
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Apr. 18, 2017
  • Patent Title: Synthesis of intermediate for treprostinil production Apr. 04, 2017
  • Patent Title: Process to prepare treprostinil, the active ingredient in remodulin® Mar. 28, 2017
  • Patent Title: Process to prepare treprostinil, the active ingredient in remodulin® Mar. 14, 2017
  • Patent Title: Synthesis of intermediates for producing prostacyclin derivatives Mar. 14, 2017
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Aug. 23, 2016
  • Patent Title: Method of identifying therapies for pulmonary hypertension Jul. 12, 2016
  • Patent Title: Treprostinil administration by inhalation Jun. 07, 2016
  • Patent Title: Treprostinil administration by inhalation May. 17, 2016
  • Patent Title: Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same May. 03, 2016
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Mar. 08, 2016
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Dec. 01, 2015
  • Patent Title: Process to prepare treprostinil, the active ingredient in remodulin® Oct. 13, 2015
  • Patent Title: Dosage inhaler Oct. 13, 2015
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Jun. 09, 2015
  • Patent Title: Iminosugars and methods of treating viral diseases Jun. 02, 2015
  • Patent Title: Treatment for pulmonary hypertension Mar. 03, 2015
  • Patent Title: Treprostinil production Jan. 27, 2015
  • Patent Title: Use of treprostinil to treat and prevent ischemic lesions Jul. 01, 2014
  • Patent Title: Process to prepare treprostinil Jun. 10, 2014
  • Patent Title: Iminosugars and methods of treating togaviral diseases Jun. 10, 2014
  • Patent Title: Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same Feb. 25, 2014
  • Patent Title: Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same Feb. 18, 2014
  • Patent Title: Nebulized liposomes for the pulmonary application of drug compounds Feb. 18, 2014
  • Patent Title: Treatment for pulmonary hypertension Dec. 17, 2013
  • Patent Title: Use of treprostinil to treat neuropathic diabetic foot ulcers Oct. 22, 2013
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Sep. 17, 2013
  • Patent Title: Process to prepare treprostinil, the active ingredient in remodulin® Jul. 30, 2013
  • Patent Title: Treprostinil production Jul. 09, 2013
  • Patent Title: Synthesis of intermediate for treprostinil production Jun. 11, 2013
  • Patent Title: Combinatorial library approach to iminocyclitols with biological activity May. 21, 2013
  • Patent Title: Iminosugars and methods of treating bunyaviral and togaviral diseases Apr. 23, 2013
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Apr. 02, 2013
  • Patent Title: Iminosugars and methods of treating bunyaviral and togaviral diseases Feb. 05, 2013
  • Patent Title: Treprostinil formulation Jan. 08, 2013
  • Patent Title: Solid formulations of prostacyclin analogs Jan. 08, 2013
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Aug. 28, 2012
  • Patent Title: Process to prepare treprostinil, the active ingredient in remodulin Aug. 14, 2012
  • Patent Title: Compounds and methods for delivery of prostacyclin analogs Jul. 31, 2012
  • Patent Title: Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same Aug. 16, 2011
  • Patent Title: Use of treprostinil to treat neuropathic diabetic foot ulcers Feb. 01, 2011
  • Patent Title: Cooperative processing with mobile monitoring device and computer system May. 11, 2010
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded to UTHR from public contracts

UTHR News

Recent insights relating to UTHR

CNBC Recommendations

Recent picks made for UTHR stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in UTHR

UTHR Analyst Ratings

UTHR Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
UTHR Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $UTHR stock a Buy, Sell, or Hold?

  • What is the price target for $UTHR stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

UTHR Top Shareholders
Shareholder
Shares Held
UTHR Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $UTHR stock?

  • Who owns the most shares of $UTHR stock?

  • What funds own $UTHR stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

UTHR Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view UTHR Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About UTHR

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

  • Address Silver Spring, MD
  • Market Cap 21.3 billion
  • Employees 1,400
  • Industrial Classification Pharmaceutical Preparations

United Therapeutics Corp (UTHR) Historical Stock Prices

United Therapeutics Corp (UTHR) closed at $497.59 on September 22, 2026. Over the past year its adjusted close ranged from $414.73 to $596.76. Daily prices go back to January 2, 2014, 3,199 trading days in all.

  • 1 month-3.03%
  • 3 months-8.59%
  • Year to date+2.12%
  • 1 year+19.98%
  • 3 years+123.38%
  • 5 years+148.21%
  • Max+348.68%
See every congressional and insider trade on the UTHR price chart

Quiver Premium charts UTHR's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 22, 2026 493.98 499.58 488.08 497.59 497.59 586,401
Sep 21, 2026 497.70 497.70 491.25 493.10 493.10 1,185,699
Sep 18, 2026 498.07 499.23 492.57 494.63 494.63 1,501,108
Sep 17, 2026 501.49 503.32 492.59 497.27 497.27 1,454,415
Sep 16, 2026 500.62 505.77 497.67 498.48 498.48 488,401
Sep 15, 2026 505.44 507.15 498.85 500.35 500.35 1,604,664
Sep 14, 2026 506.78 509.06 499.62 502.70 502.70 605,734
Sep 11, 2026 505.60 508.68 496.18 497.11 497.11 573,361
Sep 10, 2026 502.44 509.79 497.91 503.86 503.86 653,159
Sep 9, 2026 502.75 509.52 492.90 506.82 506.82 500,105
Sep 8, 2026 494.74 505.00 479.71 497.97 497.97 643,543
Sep 4, 2026 484.33 494.08 484.33 487.61 487.61 327,024
Sep 3, 2026 494.09 494.09 477.06 490.24 490.24 469,576
Sep 2, 2026 510.00 510.05 477.01 492.02 492.02 1,404,131
Sep 1, 2026 514.20 517.75 510.39 512.70 512.70 478,996
Aug 31, 2026 510.95 515.55 507.03 510.38 510.38 538,523
Aug 28, 2026 527.94 530.50 513.72 515.46 515.46 266,869
Aug 27, 2026 513.98 531.76 511.00 527.91 527.91 391,005
Aug 26, 2026 515.60 522.02 513.98 516.68 516.68 254,780
Aug 25, 2026 516.07 520.65 515.54 518.53 518.53 876,497
Aug 24, 2026 513.12 514.29 508.15 512.88 512.88 323,887
Aug 21, 2026 523.23 528.02 512.29 513.12 513.12 415,573
Aug 20, 2026 524.15 529.25 517.88 521.00 521.00 440,385
Aug 19, 2026 525.47 535.77 522.04 529.14 529.14 432,111
Aug 18, 2026 510.42 519.21 508.56 518.27 518.27 366,432
Aug 17, 2026 502.29 509.54 499.96 508.48 508.48 457,341
Aug 14, 2026 498.91 501.62 494.35 499.73 499.73 472,955
Aug 13, 2026 515.62 515.62 499.19 501.27 501.27 408,059
Aug 12, 2026 510.44 521.43 506.01 511.72 511.72 326,125
Aug 11, 2026 528.06 534.41 512.47 515.50 515.50 343,389
Aug 10, 2026 528.60 540.56 523.37 529.66 529.66 642,772
Aug 7, 2026 534.84 541.03 524.58 538.84 538.84 1,198,817
Aug 6, 2026 519.79 533.12 511.99 532.94 532.94 998,775
Aug 5, 2026 505.00 525.78 490.80 519.01 519.01 742,761
Aug 4, 2026 517.86 521.18 511.93 518.68 518.68 522,267
Aug 3, 2026 516.29 519.74 514.01 516.31 516.31 427,627
Jul 31, 2026 525.84 525.84 514.34 517.71 517.71 616,616
Jul 30, 2026 522.30 528.96 521.80 525.82 525.82 472,490
Jul 29, 2026 526.08 526.17 517.61 524.70 524.70 560,581
Jul 28, 2026 530.84 532.45 522.10 523.63 523.63 446,331
Jul 27, 2026 529.71 535.22 524.81 527.94 527.94 431,349
Jul 24, 2026 533.94 537.75 527.75 528.47 528.47 313,248
Jul 23, 2026 523.23 532.12 519.01 529.53 529.53 241,123
Jul 22, 2026 535.83 541.25 521.73 527.07 527.07 469,813
Jul 21, 2026 526.37 537.48 523.31 535.83 535.83 467,386
Jul 20, 2026 535.55 536.41 528.56 529.34 529.34 318,879
Jul 17, 2026 529.29 543.56 528.39 535.67 535.67 422,243
Jul 16, 2026 533.61 537.47 527.60 529.05 529.05 350,858
Jul 15, 2026 524.81 534.71 520.05 531.79 531.79 448,059
Jul 14, 2026 535.57 536.15 523.46 526.66 526.66 372,647
Jul 13, 2026 541.47 543.05 530.09 535.57 535.57 303,818
Jul 10, 2026 550.59 553.47 539.33 547.06 547.06 307,778
Jul 9, 2026 552.18 556.26 547.61 552.48 552.48 302,782
Jul 8, 2026 561.49 563.25 548.00 554.34 554.34 299,415
Jul 7, 2026 559.06 563.70 552.80 563.70 563.70 513,745
Jul 6, 2026 556.31 556.45 543.82 547.25 547.25 326,595
Jul 2, 2026 554.94 558.59 547.62 555.91 555.91 534,365
Jul 1, 2026 542.65 549.66 536.93 547.15 547.15 422,598
Jun 30, 2026 547.42 552.46 535.63 541.83 541.83 551,070
Jun 29, 2026 545.58 549.38 539.14 544.92 544.92 420,258
Jun 26, 2026 544.37 554.51 535.44 542.66 542.66 1,022,244
Jun 25, 2026 547.26 555.32 540.90 543.39 543.39 285,355
Jun 24, 2026 544.94 555.00 544.06 549.90 549.90 377,592
Jun 23, 2026 542.08 546.58 539.70 544.33 544.33 1,081,315
Jun 22, 2026 541.25 541.53 533.49 538.30 538.30 620,875
Jun 18, 2026 553.18 555.23 532.59 536.59 536.59 2,001,977
Jun 17, 2026 549.36 555.92 547.01 551.47 551.47 360,276
Jun 16, 2026 553.43 555.23 544.56 548.27 548.27 611,912
Jun 15, 2026 545.96 554.09 538.71 549.57 549.57 351,708
Jun 12, 2026 547.59 547.59 536.39 545.96 545.96 451,832
Jun 11, 2026 544.86 552.72 543.00 545.40 545.40 428,970
Jun 10, 2026 553.39 557.97 538.27 544.10 544.10 576,435
Jun 9, 2026 550.89 554.48 544.00 553.14 553.14 340,480
Jun 8, 2026 545.50 553.09 544.02 544.69 544.69 448,559
Jun 5, 2026 547.10 550.99 540.80 549.87 549.87 663,249
Jun 4, 2026 549.47 551.89 537.34 547.69 547.69 411,934
Jun 3, 2026 543.50 552.00 541.10 549.47 549.47 326,119
Jun 2, 2026 537.56 544.91 534.97 540.05 540.05 438,096
Jun 1, 2026 551.70 560.97 544.49 544.62 544.62 498,538
May 29, 2026 563.04 563.04 548.03 556.82 556.82 657,447
May 28, 2026 571.27 574.00 560.15 562.09 562.09 537,379
May 27, 2026 578.74 580.39 569.86 570.75 570.75 338,709
May 26, 2026 564.61 578.80 560.60 578.43 578.43 965,712
May 22, 2026 567.30 570.64 563.04 568.43 568.43 281,044
May 21, 2026 562.50 567.56 555.25 565.87 565.87 420,900
May 20, 2026 570.37 578.60 560.89 563.93 563.93 485,813
May 19, 2026 566.99 572.45 560.23 566.80 566.80 404,045
May 18, 2026 570.00 571.23 561.01 566.99 566.99 309,658
May 15, 2026 576.49 576.49 565.26 568.58 568.58 334,196
May 14, 2026 579.35 579.55 568.72 575.79 575.79 373,619
May 13, 2026 581.17 584.71 574.84 579.54 579.54 329,510
May 12, 2026 569.85 583.83 568.61 581.74 581.74 397,479
May 11, 2026 566.96 580.45 566.96 569.88 569.88 460,695
May 8, 2026 569.17 573.52 561.20 564.94 564.94 628,487
May 7, 2026 599.00 599.00 568.75 569.18 569.18 830,890
May 6, 2026 589.47 609.35 575.00 596.76 596.76 660,288
May 5, 2026 581.22 585.59 567.00 572.20 572.20 582,986
May 4, 2026 568.35 582.77 565.02 581.22 581.22 376,175
May 1, 2026 569.00 573.30 565.56 570.40 570.40 186,136
Apr 30, 2026 574.45 579.58 568.41 571.35 571.35 388,260
Apr 29, 2026 564.76 575.00 561.00 571.07 571.07 223,892
Apr 28, 2026 571.64 579.00 564.64 569.11 569.11 365,411
Apr 27, 2026 567.16 575.06 565.00 566.99 566.99 242,375
Apr 24, 2026 572.70 572.70 560.16 567.16 567.16 301,756
Apr 23, 2026 574.76 579.31 569.11 572.85 572.85 292,136
Apr 22, 2026 573.68 580.65 570.36 574.29 574.29 514,668
Apr 21, 2026 573.26 576.06 563.65 573.46 573.46 350,394
Apr 20, 2026 593.65 593.65 571.65 573.44 573.44 377,538
Apr 17, 2026 578.88 592.48 574.59 588.38 588.38 682,466
Apr 16, 2026 575.00 581.92 573.34 580.51 580.51 474,743
Apr 15, 2026 581.38 584.54 575.00 577.58 577.58 491,483
Apr 14, 2026 575.00 582.39 572.73 578.54 578.54 440,967
Apr 13, 2026 571.33 580.07 569.70 577.63 577.63 482,888
Apr 10, 2026 576.06 576.74 566.12 571.73 571.73 443,232
Apr 9, 2026 576.00 582.45 571.90 574.77 574.77 415,385
Apr 8, 2026 571.77 586.01 560.59 581.69 581.69 575,393
Apr 7, 2026 562.85 571.03 557.25 565.70 565.70 726,512
Apr 6, 2026 566.14 567.38 552.54 559.65 559.65 504,979
Apr 2, 2026 565.00 577.86 551.30 564.81 564.81 831,084
Apr 1, 2026 596.88 597.00 570.22 570.27 570.27 755,030
Mar 31, 2026 583.62 599.00 571.71 592.98 592.98 1,461,355
Mar 30, 2026 605.22 607.89 580.07 588.36 588.36 1,722,230
Mar 27, 2026 534.11 535.33 520.97 522.83 522.83 338,243
Mar 26, 2026 534.65 541.16 530.82 532.53 532.53 497,910
Mar 25, 2026 536.94 549.50 535.95 541.60 541.60 723,481
Mar 24, 2026 520.14 536.02 517.59 531.82 531.82 579,152
Mar 23, 2026 529.02 537.00 517.80 521.22 521.22 514,539
Mar 20, 2026 522.58 529.94 520.00 524.28 524.28 796,634
Mar 19, 2026 528.36 533.73 524.30 527.00 527.00 505,500
Mar 18, 2026 538.68 540.59 523.50 530.35 530.35 409,713
Mar 17, 2026 533.51 541.21 530.00 540.02 540.02 402,326
Mar 16, 2026 535.44 538.51 527.46 534.30 534.30 444,485
Mar 13, 2026 533.83 543.37 533.83 536.12 536.12 544,885
Mar 12, 2026 539.84 545.00 531.78 532.82 532.82 622,175
Mar 11, 2026 530.15 545.48 528.64 544.71 544.71 1,477,201
Mar 10, 2026 525.86 548.12 525.86 535.81 535.81 785,715
Mar 9, 2026 497.75 530.47 495.50 529.17 529.17 1,155,655
Mar 6, 2026 478.05 484.73 471.29 478.16 478.16 315,915
Mar 5, 2026 490.00 490.00 478.77 485.06 485.06 420,756
Mar 4, 2026 496.83 500.17 485.32 490.21 490.21 535,267
Mar 3, 2026 509.20 512.97 490.74 498.65 498.65 451,729
Mar 2, 2026 509.55 527.14 506.00 513.82 513.82 747,626
Feb 27, 2026 503.70 507.93 491.97 503.90 503.90 610,219
Feb 26, 2026 530.01 532.25 496.44 503.60 503.60 764,151
Feb 25, 2026 480.00 537.19 478.13 535.10 535.10 1,046,631
Feb 24, 2026 473.61 475.69 466.56 473.43 473.43 350,332
Feb 23, 2026 472.68 476.11 466.00 474.52 474.52 285,616
Feb 20, 2026 479.13 480.52 467.52 473.42 473.42 274,243
Feb 19, 2026 477.28 482.26 470.76 480.52 480.52 219,910
Feb 18, 2026 478.96 481.70 472.48 476.05 476.05 218,019
Feb 17, 2026 474.68 486.33 470.04 482.42 482.42 332,731
Feb 13, 2026 478.90 484.98 471.00 473.66 473.66 258,650
Feb 12, 2026 475.45 479.14 469.83 476.13 476.13 214,813
Feb 11, 2026 474.65 475.85 464.44 475.85 475.85 178,484
Feb 10, 2026 475.01 475.69 468.62 473.20 473.20 234,018
Feb 9, 2026 486.15 486.25 469.69 473.12 473.12 320,354
Feb 6, 2026 483.81 489.50 481.95 485.36 485.36 297,163
Feb 5, 2026 480.66 487.32 476.95 478.93 478.93 432,771
Feb 4, 2026 481.97 487.50 472.51 482.59 482.59 490,461
Feb 3, 2026 474.23 480.86 470.82 478.27 478.27 281,607
Feb 2, 2026 467.17 475.65 466.01 475.00 475.00 351,565
Jan 30, 2026 465.71 470.87 462.02 469.49 469.49 373,170
Jan 29, 2026 466.78 472.41 465.50 467.70 467.70 260,792
Jan 28, 2026 474.29 476.59 465.60 467.30 467.30 274,153
Jan 27, 2026 473.83 479.41 472.69 476.78 476.78 267,328
Jan 26, 2026 469.48 474.97 466.81 473.36 473.36 352,413
Jan 23, 2026 472.83 474.99 464.16 468.94 468.94 248,918
Jan 22, 2026 468.86 472.97 467.25 472.06 472.06 254,005
Jan 21, 2026 469.29 473.89 465.28 469.77 469.77 326,894
Jan 20, 2026 460.98 470.98 455.63 468.07 468.07 420,354
Jan 16, 2026 468.70 470.08 461.45 464.93 464.93 397,705
Jan 15, 2026 475.59 476.45 467.68 471.99 471.99 292,302
Jan 14, 2026 476.60 481.29 470.05 475.73 475.73 376,615
Jan 13, 2026 484.22 484.22 474.02 476.86 476.86 340,262
Jan 12, 2026 483.44 485.76 475.27 482.39 482.39 391,784
Jan 9, 2026 492.13 493.27 482.33 483.23 483.23 410,507
Jan 8, 2026 503.88 504.59 486.33 490.83 490.83 329,861
Jan 7, 2026 503.85 509.40 501.07 503.69 503.69 302,963
Jan 6, 2026 495.01 512.74 494.29 502.71 502.71 306,685
Jan 5, 2026 496.96 498.77 479.59 489.69 489.69 619,700
Jan 2, 2026 490.07 501.70 480.02 496.72 496.72 522,796
Dec 31, 2025 495.13 496.54 486.51 487.25 487.25 348,462
Dec 30, 2025 502.84 504.90 494.25 496.19 496.19 239,382
Dec 29, 2025 508.98 509.85 500.79 502.90 502.90 256,628
Dec 26, 2025 514.88 515.00 505.04 507.16 507.16 185,786
Dec 24, 2025 512.89 516.08 508.83 514.64 514.64 194,586
Dec 23, 2025 512.12 519.99 509.12 510.44 510.44 382,753
Dec 22, 2025 517.13 519.65 510.64 513.79 513.79 410,977
Dec 19, 2025 505.45 518.61 503.69 517.13 517.13 1,689,646
Dec 18, 2025 507.08 513.57 498.76 507.00 507.00 614,808
Dec 17, 2025 500.12 513.93 499.30 510.94 510.94 613,519
Dec 16, 2025 497.17 502.77 491.76 500.00 500.00 488,772
Dec 15, 2025 491.77 501.05 483.52 500.30 500.30 535,436
Dec 12, 2025 491.00 496.73 488.75 493.99 493.99 638,833
Dec 11, 2025 482.98 488.99 482.00 488.51 488.51 334,299
Dec 10, 2025 479.62 486.23 477.54 484.86 484.86 371,859
Dec 9, 2025 477.88 482.94 474.72 476.36 476.36 299,199
Dec 8, 2025 488.97 489.99 474.59 479.51 479.51 468,637
Dec 5, 2025 484.65 489.94 481.61 489.31 489.31 303,006
Dec 4, 2025 480.63 486.46 477.56 484.10 484.10 630,755
Dec 3, 2025 474.14 482.67 470.13 480.96 480.96 301,473
Dec 2, 2025 480.14 484.24 473.51 474.14 474.14 308,992
Dec 1, 2025 484.68 486.33 477.41 479.95 479.95 385,491
Nov 28, 2025 490.25 490.30 484.35 486.00 486.00 168,092
Nov 26, 2025 485.77 492.62 483.00 488.43 488.43 329,977
Nov 25, 2025 480.86 486.20 471.05 485.77 485.77 298,361
Nov 24, 2025 472.09 482.43 466.72 477.20 477.20 760,687
Nov 21, 2025 473.37 477.63 468.51 474.82 474.82 444,518
Nov 20, 2025 477.77 482.31 473.21 474.72 474.72 417,426
Nov 19, 2025 473.82 480.90 472.10 476.54 476.54 466,746
Nov 18, 2025 469.96 485.32 469.96 476.59 476.59 599,896
Nov 17, 2025 466.40 476.70 463.93 471.92 471.92 505,766
Nov 14, 2025 460.34 470.86 460.34 466.40 466.40 426,185
Nov 13, 2025 457.21 469.58 456.00 462.30 462.30 403,799
Nov 12, 2025 455.97 463.88 452.44 461.54 461.54 442,415
Nov 11, 2025 450.18 464.27 449.58 459.21 459.21 410,638
Nov 10, 2025 449.22 456.61 445.81 453.93 453.93 518,512
Nov 7, 2025 452.81 453.98 444.04 448.91 448.91 372,830
Nov 6, 2025 448.00 456.41 445.25 454.00 454.00 376,508
Nov 5, 2025 432.53 449.82 432.53 447.45 447.45 442,178
Nov 4, 2025 432.75 440.00 430.02 437.33 437.33 618,396
Nov 3, 2025 441.39 446.00 432.00 438.66 438.66 580,473
Oct 31, 2025 451.60 452.52 440.50 445.43 445.43 753,608
Oct 30, 2025 451.29 456.75 445.87 453.53 453.53 544,906
Oct 29, 2025 415.37 479.50 415.26 455.32 455.32 1,867,356
Oct 28, 2025 418.17 419.46 409.07 415.34 415.34 805,586
Oct 27, 2025 420.63 422.39 411.92 421.04 421.04 446,666
Oct 24, 2025 426.40 430.16 418.22 418.58 418.58 394,974
Oct 23, 2025 424.16 426.61 420.69 426.21 426.21 453,293
Oct 22, 2025 422.54 424.12 419.47 421.64 421.64 463,682
Oct 21, 2025 432.20 432.20 422.51 422.53 422.53 447,652
Oct 20, 2025 434.22 436.00 419.54 432.69 432.69 645,022
Oct 17, 2025 432.23 435.38 428.04 433.34 433.34 524,679
Oct 16, 2025 430.13 435.36 427.86 432.69 432.69 496,058
Oct 15, 2025 433.42 441.78 429.84 432.19 432.19 658,837
Oct 14, 2025 437.53 442.23 430.80 433.61 433.61 665,453
Oct 13, 2025 437.53 443.11 430.89 440.06 440.06 442,389
Oct 10, 2025 445.66 446.16 439.18 440.00 440.00 690,855
Oct 9, 2025 449.83 452.70 444.05 445.38 445.38 573,913
Oct 8, 2025 456.52 456.52 444.00 448.93 448.93 540,941
Oct 7, 2025 450.31 459.48 449.51 456.84 456.84 610,701
Oct 6, 2025 445.24 455.26 445.24 453.28 453.28 692,585
Oct 3, 2025 443.63 455.12 443.44 453.07 453.07 796,289
Oct 2, 2025 433.24 444.56 432.56 443.44 443.44 969,713
Oct 1, 2025 421.26 439.57 419.21 438.18 438.18 810,210
Sep 30, 2025 422.99 428.42 417.08 419.21 419.21 1,140,255
Sep 29, 2025 429.18 431.75 415.00 424.31 424.31 1,072,233
Sep 26, 2025 426.86 433.57 422.99 432.66 432.66 724,618
Sep 25, 2025 434.72 437.68 421.50 425.42 425.42 966,491
Sep 24, 2025 428.71 442.01 425.66 438.75 438.75 1,017,599
Sep 23, 2025 413.34 438.26 413.02 434.06 434.06 1,141,192
Sep 22, 2025 419.47 420.58 412.96 414.73 414.73 696,007

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
United Therapeutics Corp Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at UTHR, per a recent SEC DEF 14A filing. We estimate that the median employee at UNITED THERAPEUTICS Corp is paid $211,298.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation